Provident Company of the Employees of the Hebrew University’s Biogen BIIB Stock Holding History

Provident Company of the Employees of the Hebrew University’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,529	Closed	-$2.2M	–	28
2025 Q4	$2.2M	Hold	12,529	–	–	2.29%	17
2025 Q3	$1.75M	Hold	12,529	–	–	1.75%	24
2025 Q2	$1.57M	Hold	12,529	–	–	1.57%	24
2025 Q1	$1.71M	Buy	12,529 +3,470	+38%	+$496K	1.97%	22
2024 Q4	$1.38M	Buy	9,059 +4,416	+95%	+$745K	1.61%	24
2024 Q3	$900K	Hold	4,643	–	–	1.01%	27
2024 Q2	$1.08M	Buy	4,643 +12	+0.3%	+$2.61K	1.28%	26
2024 Q1	$999K	Buy	+4,631	New	+$1.08M	1.06%	31

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Provident Company of the Employees of the Hebrew University's BIIB Position: Q1 2026 in Review

Provident Company of the Employees of the Hebrew University sold out of Biogen (BIIB) in Q1 2026, closing a stake of 12,529 shares — an estimated $2.2M sold.

Provident Company of the Employees of the Hebrew University first reported a position in BIIB in Q1 2024 and held it in 8 quarters. The position peaked at $2.2M in Q4 2025. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Provident Company of the Employees of the Hebrew University reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
Provident Company of the Employees of the Hebrew University sold 12,529 Biogen shares in Q1 2026, an estimated $2.2M.
Provident Company of the Employees of the Hebrew University first reported a position in Biogen in Q1 2024 and held it in 8 quarters.
Provident Company of the Employees of the Hebrew University's Biogen position peaked at $2.2M in Q4 2025.
1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Provident Company of the Employees of the Hebrew University's 13F filing for Q1 2026, filed 12 May 2026.